DTL
ARQT icon

Dynamic Technology Lab’s Arcutis Biotherapeutics ARQT Stock Holding History

Dynamic Technology Lab’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,603
Closed -$245K – 988
2024
Q4 		$245K Buy
+17,603
New +$193K 0.04% 705
2023
Q1 		– Sell
-10,521
Closed -$156K – 1077
2022
Q4 		$156K Buy
+10,521
New +$184K 0.02% 949

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dynamic Technology Lab's ARQT Position: Q1 2025 in Review

Dynamic Technology Lab sold out of Arcutis Biotherapeutics (ARQT) in Q1 2025, closing a stake of 17,603 shares — an estimated $245K sold.

Dynamic Technology Lab first reported a position in ARQT in Q4 2022 and held it in 2 quarters. The position peaked at $245K in Q4 2024. 241 funds tracked by Wall St. Rank hold ARQT as of Q1 2025.

  • Dynamic Technology Lab reported no remaining Arcutis Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,603 Arcutis Biotherapeutics shares in Q1 2025, an estimated $245K.
  • Dynamic Technology Lab first reported a position in Arcutis Biotherapeutics in Q4 2022 and held it in 2 quarters.
  • Dynamic Technology Lab's Arcutis Biotherapeutics position peaked at $245K in Q4 2024.
  • 241 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q1 2025.

Based on Dynamic Technology Lab's 13F filing for Q1 2025, filed 16 May 2025.